B2M and mycosis fungoides: Other clinicopathologic variables such as age, sex, ethnicity, previous history of malignancy, history of previous treatments for MF, β2M levels, clinical presentation, immunophenotype, and TCR gene rearrangement had no statistically significant differences between the compared groups.